Loading...
Loading...
Sanofi
Sanofi. Spoken Alpha tracks SNYNF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks SNYNF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SNYNF.
curl https://api.spokenalpha.com/v1/companies/SNYNF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.14 | $2.41 | +30.3% | +2.4% | +4.3% |
| Q4 FY2026 | $2.89 | $2.27 | +27.3% | +6.3% | +5.2% |
| Q3 FY2026 | $2.76 | $2.32 | +18.9% | +7.2% | +5.7% |
| Q2 FY2026 | $3.04 | $2.38 | +27.7% | +7.4% | +5.0% |
| Q1 FY2025 | $2.82 | $2.40 | +17.3% | -0.5% | 0.0% |
| Q4 FY2025 | $2.91 | $2.36 | +23.1% | +8.0% | +6.7% |
| Q3 FY2025 | $2.96 | $2.45 | +21.0% | -1.5% | -1.3% |
| Q2 FY2025 | $2.84 | $2.35 | +20.7% | -0.5% | +0.3% |
| Q1 FY2024 | $3.24 | $2.61 | +24.2% | +3.8% | +2.2% |
| Q4 FY2024 | $3.20 | $2.61 | +22.7% | -0.9% | -1.5% |